{"id":4665,"date":"2026-05-06T09:04:29","date_gmt":"2026-05-06T07:04:29","guid":{"rendered":"https:\/\/ksbbiotech.com\/?page_id=4665"},"modified":"2026-06-06T16:07:45","modified_gmt":"2026-06-06T14:07:45","slug":"ca153","status":"publish","type":"page","link":"https:\/\/ksbbiotech.com\/zh\/ca153\/","title":{"rendered":"\u764c\u6297\u539f 15-3 (CA15-3)"},"content":{"rendered":"\t\t
PDB ID: 7V3Q. Source: RCSB Protein Data Bank<\/span><\/span>. For illustration purposes only.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t The VeriGoldTM<\/sup> Cancer Antigen 15-3 (CA 15-3) Rapid Test is a chromatographic immunoassay designed for the quantitative measurement of the CA 15-3 tumor-associated antigen in human serum or plasma. CA 15-3 is commonly associated with breast cancer and is used as a biomarker to support clinical assessment in patients with established disease. The assay provides rapid, point-of-care results, enabling timely evaluation of tumor marker levels without requiring centralized laboratory testing.<\/p> This test is indicated for serial monitoring of patients with confirmed breast cancer, particularly those with elevated CA 15-3 levels at diagnosis. It is intended to assist in tracking disease progression and evaluating treatment response over time. As CA 15-3 can also be influenced by non-malignant conditions, results must always be interpreted together with clinical findings and other diagnostic data.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\tVeriGoldTM<\/sup> CA15-3<\/h2>\t\t\t\t<\/div>\n\t\t\t\t